Braxia Scientific Corp.

    Braxia Scientific Corp.

    CCSE:BRAX
    0.01
    CAD
    +0.00
    (-50.00%)
    Braxia Scientific Corp.
    CSE:BRAX
    (Canadian Securities Exchange)

    Recent

    price

    0.01

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2020
    2021
    2022
    2023
    TTM
    CAD
    - -
    0.01
    0.01
    0.01
    0.01
    Revenue per Share
    - -
    -0.56
    -0.07
    -0.06
    -0.04
    Basic EPS, GAAP
    - -
    -0.03
    -0.03
    -0.04
    -0.01
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    0.11
    0.09
    0.05
    0.01
    - -
    Book Value per Share
    0.07
    0.05
    0.04
    - -
    - -
    Tangible Book Value per Share
    - -
    158
    175
    228
    251
    Basic Weighted Avg Shares
    - -
    1
    1
    2
    2
    Sales/Revenue/Turnover
    - -
    -1,043.84
    -479.77
    -394.39
    -189.91
    Operating Margin (%)
    - -
    - -
    - -
    1
    - -
    Depreciation Expense
    - -
    -89
    -12
    -13
    -10
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    -8,809.07
    -815.93
    -697.48
    -436.37
    Profit Margin (%)
    12
    9
    7
    - -
    -2
    Working Capital
    - -
    - -
    - -
    - -
    1
    LT Debt
    20
    16
    9
    2
    - -
    Total Equity
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    -495.56
    -97.65
    -248.72
    -735.47
    Return on Common Equity (%)

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Jun'24
    Sep'24
    Dec'24
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    264
    264
    264
    Market Capitalization
    5
    3
    1

    Working Capital

    CAD

    •

    in mil. unless spec.
    Jun'24
    Sep'24
    Dec'24
    Total Current Assets
    1
    1
    - -
    Cash, Cash Equivalents & STI
    1
    1
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    2
    2
    2
    Payables & Accruals
    2
    2
    2
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    -82.1%
    Free Cash Flow
    - -
    - -
    82.71%
    Net Income, GAAP
    - -
    - -
    8.3%
    Sales/Revenue/Turnover
    - -
    - -
    26.7%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    1
    2023
    - -
    - -
    - -
    1
    2
    2024
    1
    1
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.01
    -0.01
    -0.01
    - -
    -0.07
    2023
    - -
    -0.01
    -0.01
    - -
    -0.06
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • newsfilecorp.com

      Braxia Scientific Update

    • newsfilecorp.com

      Braxia Scientific Announces Change in Directors and CEO

    • newsfilecorp.com

      Braxia Scientific Announces Voting Results from the Annual General and Special Meeting of Shareholders

    • newsfilecorp.com

      Braxia Announces Annual General and Special Meeting

    • newsfilecorp.com

      Braxia Scientific Announces Cease Trade Order

    • newsfilecorp.com

      Braxia Scientific Provides Update on Application for Management Cease Trade Order

    • newsfilecorp.com

      Braxia Scientific Announces Application for a Management Cease Trade Order For Late Filing of Audited Annual Financial Statements

    • newsfilecorp.com

      Braxia Scientific Reports Q3 2024 Financial Results

    • newsfilecorp.com

      Braxia Scientific Reports Mandatory Conversion of Debentures

    • newsfilecorp.com

      Braxia Scientific Reports Q2 2024 Financial Results and Provides Corporate Update

    • newsfilecorp.com

      Braxia Scientific Reports Q1 Fiscal 2024 Financial Results

    • newsfilecorp.com

      Braxia Scientific Reports Fiscal 2023 Financial Results

    • proactiveinvestors.com

      Braxia Scientific reports significant increase in treatment volumes across its clinics

    • proactiveinvestors.com

      Braxia Scientific announces termination of Irwin Naturals merger LOI; retains strategic clinical assets

    • proactiveinvestors.com

      Braxia Scientific reports 50.5% increase in 3Q revenue; updates on acquisition by Irwin Naturals

    • proactiveinvestors.com

      Braxia Scientific closes first tranche of its non-brokered offering for aggregate proceeds of $751,218.83

    • proactiveinvestors.com

      Braxia Scientific announces up to $1.5M offering and concurrent private placement

    • proactiveinvestors.com

      Irwin Naturals announces LOI to acquire Braxia Scientific to create new market leader

    • proactiveinvestors.ca

      Irwin Naturals an Braxia Scientific partner to accelerate in-human development of new therapies for mental health

    • proactiveinvestors.com

      Braxia Scientific sees Q2 revenue increase, with in-clinic treatment up 34.5%